Comparison of noninvasive prenatal screening with combined first‐trimester screening as a frontline screening approach for common trisomies in a public hospital in Australia
Australian and New Zealand Journal of Obstetrics and Gynaecology · 2023-10 · 63 (5) · 666-672
DOI: 10.1111/ajo.13605 ↗Kurz gefasst
Fachartikel in der Zeitschrift Australian and New Zealand Journal of Obstetrics and Gynaecology, 2022-09. Verfasst von Katie Battese Ellis und 3 weiteren Autor:innen. Beteiligte Einrichtung: Genea, Sydney, New South Wales, Australia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Illumina Inc. Melbourne, VIC, Australia.
Abstract (Originalsprache)
Background
Combined first‐trimester screening (cFTS) for fetal anomalies involves maternal serum screening for biochemical markers and measurement of the nuchal translucency (NT) by ultrasound. Noninvasive prenatal screening (NIPS) analyses cell‐free DNA present in a maternal blood sample for presence of fetal chromosomal aneuploidies.
Aims
To compare NIPS with cFTS as frontline screening in a public hospital in Australia. Materials and methods Women were offered NIPS in addition to the usual cFTS routinely offered to all women at a public hospital in NSW, Australia. The cFTS sample was collected at ten weeks' gestation and the NIPS sample at 12 weeks' gestation at the ultrasound appointment.
Results
In a low‐risk population of 997 women, frontline NIPS had a screen‐positive rate of 0.5% (5/997) vs 4.2% (42/997) with cFTS. cFTS correctly identified one trisomy 21 case and one trisomy 18 case; however, there were two trisomy 18 false negatives. Of five positive NIPS calls, four were correctly identified as trisomy 21 (one) and trisomy 18 (three); there were no NIPS false negatives. Overall, the false‐positive rate with NIPS was 0.1% vs 4.0% by cFTS.
Conclusions
The lower screen‐positive rate with NIPS for common trisomies was a result of the significantly lower false‐positive rate with NIPS. Consequently, NIPS as first‐line screening, even if funded by the hospital, may provide cost savings. We believe NIPS should be used from ten weeks' gestation in conjunction with morphology ultrasound for routine first‐trimester prenatal management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Genea, Sydney, New South Wales, Australia.
- Perinatal Ultrasound Unit, Nepean Hospital, Penrith, New South Wales, Australia.
ORCID-Profile: Michael Bonifacio
Förderung
- Illumina Inc. Melbourne, VIC, Australia
Zitieren
APA
Battese Ellis, K., Sathasivam, N., Bonifacio, M., & Benzie, R. (2023). Comparison of noninvasive prenatal screening with combined first‐trimester screening as a frontline screening approach for common trisomies in a public hospital in Australia. Australian and New Zealand Journal of Obstetrics and Gynaecology, 63(5), 666-672. https://doi.org/10.1111/ajo.13605
Vancouver
Battese Ellis K, Sathasivam N, Bonifacio M, Benzie R. Comparison of noninvasive prenatal screening with combined first‐trimester screening as a frontline screening approach for common trisomies in a public hospital in Australia. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2023;63(5):666-672. doi:10.1111/ajo.13605
BibTeX
@article{BatteseEllis2023,
author = {Battese Ellis, Katie and Sathasivam, Nalayin and Bonifacio, Michael and Benzie, Ronald},
title = {Comparison of noninvasive prenatal screening with combined first‐trimester screening as a frontline screening approach for common trisomies in a public hospital in Australia},
journal = {Australian and New Zealand Journal of Obstetrics and Gynaecology},
year = {2023},
volume = {63},
number = {5},
pages = {666--672},
doi = {10.1111/ajo.13605}
}
EUVIMED